Abstract
Alveolar adenoma is a rare and benign pulmonary tumor, which originates from type II pneumocytes and is often incidentally identified on radiographic images. Alveolar adenoma presents as a peripleural, solitary and cystic nodule in the lung and may mimic other types of lung tumors, thus rendering its differential diagnosis difficult. Alveolar adenoma is diagnosed based on histopathological and immunohistochemical analyses. The present study describes the case of a 50-year-old male patient with alveolar adenoma. He visited a local doctor ~3 years prior due to left chest pain. A chest computed tomography scan revealed a cystic lesion in segment 8 of the left lung. A nodular shadow appeared in the cyst and gradually increased in size; the patient was thus referred to the authors' hospital. The nodule was well-defined, solitary and solid; thus, lung cancer or aspergilloma were suspected. Thoracoscopic wedge resection was performed as diagnostic therapy. The frozen sections were non-diagnostic, and a pathological examination revealed an alveolar adenoma with no evidence of malignancy and a negative culture. The patient had a good post-operative course, with no sign of recurrence at the follow-up evaluation 46 months later. On the whole, alveolar adenoma is a rare, benign pulmonary tumor that is difficult to diagnose pre-operatively.
Keywords: alveolar adenoma, benign lung tumor, tumor with air image, type II pneumocytes, lung cancer
Introduction
Alveolar adenoma (AA) is an exceedingly rare benign lung tumor that was first reported by Yousem et al in 1986(1). Patients with AA are usually asymptomatic and the tumor is incidentally detected on chest radiography as a clear solitary pulmonary nodule. When solid pulmonary nodules are >10 mm in size, there is an increased likelihood of surgical intervention due to a higher risk of malignancy and patient anxiety (2,3). A definitive diagnosis of AA depends on histopathology and immunohistochemistry findings as it is difficult to diagnose pre-operatively. Curative treatment consists of surgical resection, with no case of recurrence having been described to date in the literature, at least to the best of our knowledge.
The present study describes the case of a patient with alveolar adenoma and reports on the imaging and pathological differentiation of AA from other lung tumors.
Case report
A 50-year-old male patient presented to his previous doctor with a complaint of chest discomfort. A chest computed tomography (CT) scan revealed a 10-mm solitary nodule with a single cyst in the left lower lobe. The diameter of the pulmonary nodule increased to 14 mm within a span of 2 years (CT scan results shown in Fig. 1). He was referred to Kansai Medical University Hospital (Hirakata, Japan) due to the possibility of lung cancer. His medical history was notable for benign prostatic hyperplasia. A thoracoscopic wedge resection of the left lower lung was performed. The frozen sections were non-diagnostic, and the surgical procedure and postoperative course were uneventful, with no signs of recurrence 4 years post-operatively.
Figure 1.

Chest CT illustrating a well-defined nodule in segment 8 of the left lung with a surrounding vacuole, and the nodule increased in size on the CT scan for 2 years (images from left to right indicate the passing of time, respectively).
Overall, the tumor was well-defined and yellowish, measuring 10 mm in a subpleural cyst. Microscopically, the tumor consisted of polycystic structures resembling alveoli filled with pulmonary surfactant. The cyst lining cells were positive for thyroid transcription factor-1 (TTF-1) without atypia, corresponding to type II pneumocytes (Fig. 2). Additionally, the stroma lacked elastic fibers characteristic of alveoli and contained cluster of differentiation 34 (CD34)-positive cells with rounded nuclei and eosinophilic cytoplasm. These cells were negative for TTF-1, CD31, ERG, D2-40, SALL4, BRAF and STAT6. Immunohistochemical analysis was conducted on 4-µm-thick formalin-fixed paraffin-embedded tissue sections (details presented in Table I). Cultures were negative for fungi and tuberculosis, and no malignant cells were noted. Analyses were performed under a light microscope (Olympus Corporation) and whole slide images. Therefore, the final pathological diagnosis was that of AA.
Figure 2.
Histopathological findings of the tumor illustrating (A) multiple cystic spaces resembling alveoli (hematoxylin and eosin staining; magnification, x200). (B) Its lumen was covered with hyperplastic type II alveolar epithelial cells, which were thyroid transcription factor-1-positive (immunostaining; magnification, x400). (C) The stroma lacked elastic fibers and contained CD34-positive cells with rounded nuclei and an eosinophilic cytoplasm (immunostaining; magnification, x400).
Table I.
Antibodies used in the present case report.
| Antibody | Clone, cat. no., supplier | Dilution | Incubation | Reaction time | Fully automated IHC system, supplier | Detection system | Antigen retrieval reagent |
|---|---|---|---|---|---|---|---|
| TTF-1 | 8G7G3/1, cat. no. IR056, Dako; Agilent Technologies, Inc. | RTU | Low pH: 20 min; room temperature | 20 min | Autostainer Link 48, Agilent Technologies, Inc. | Envision FLEX | Envision FLEX Target Retrieval Solution High/Low pH |
| CD31 | JC70A, cat. no. IR610, Dako; Agilent Technologies, Inc. | RTU | High pH: 20 min; room temperature | 20 min | |||
| D2-40 | D2-40, cat. no. IR072, Dako; Agilent Technologies, Inc. | RTU | High pH: 20 min; room temperature | 3 min | |||
| ERG | Cat. no. 418111, Nichirei Biosciences, Inc. | RTU | CC1: 32 min 36˚C | 8 min | VENTANA BenchMark ULTRA PLUS, Roche Diagnostics | Optiview DAB universal kit | CC1: VENTANA ULTRA Cell Conditioning Solution |
| SALL4 | 6E3, cat. no. H00057167-M03, Abnova | x500 | CC1: 32 min 36˚C | 16 min | |||
| BRAFV600E | VE1, cat. no. 790-4855, Roche Diagnostics | RTU | CC1: 64 min 36˚C | 32 min | |||
| STAT6 | YE361, cat. no. ab32520, Abcam | x1,000 | CC1: 32 min 36˚C | 16 min |
TTF-1, thyroid transcription factor-1; SALL4, Sal-like protein 4; RTU, ready-to-use.
Discussion
AA is a rare lung tumor with an incidence rate of <1% of all lung tumors, and is classified as an adenoma in the 2015 World Health Organization Classification of lung tumors (4). AA is often asymptomatic and is incidentally detected during imaging examinations, typically exhibiting no tendency to enlarge (5). The majority of patients are middle-aged to elderly, with a slight predominance in the female sex. There is no association between the occurrence of AA and a previous medical history or family history. AA commonly occurs in the middle and lower lobes of the lung and is pathologically characterized by multifocal cystic lesions resembling alveolar cavities, with the lumen lined by TTF-1-positive type II alveolar epithelium (6). In the present study, upon an examination of the patient, it was found that the tumor had similar histopathological features to the cases reported in the literature (6-11).
AAs are characterized by the presence of vacuoles within or around the tumor on imaging (7). It is speculated that alveoli rupture and fuse to create cavities, similar to the cavity formation mechanism observed in lung cancer. This occurs as tumor cells develop toward the bronchiole, forming a unidirectional check-valve system, which results in the accumulation of gas in the alveoli. This phenomenon may explain the cystic lesions observed in the pathology. Therefore, it is important to consider AA as a differential diagnosis in cases of pulmonary nodules with air images. In the case presented herein, the tumor increased in size with the presence of air images, highlighting the necessity to distinguish the tumor from lung cancer or pulmonary aspergilloma.
The diagnosis of AA is challenging when based on small biopsy tissue or frozen sections as it can resemble normal lung parenchyma or mimic malignancy with small glandular spaces lined by regular glandular epithelium (8). Additionally, there are other conditions in the differential diagnosis of AA, including papillary adenoma, sclerosing pneumocytoma and pulmonary hamartoma. Papillary adenoma is characterized by distinctive papillae covered by uniform cuboidal to columnar cells and a heterogeneous epithelial component. The presence of TTF-1 expression in AA can help distinguish it from sclerosing pneumocytoma. Pulmonary hamartoma consists primarily of benign cartilage mixed with a fibrovascular stroma and scattered bronchial glands (9).
The curative treatment for AA is surgical resection, typically performed to rule out malignancy and confirm the diagnosis through postoperative pathology. No recurrence has been reported following complete resection (10). In the case described herein, surgery was concluded with a wedge resection as the tumor was a peripheral lesion that could be completely resected, and the frozen section did not provide a definitive diagnosis. There is a risk of unnecessary extended resection, such as segmentectomy or lobectomy, if the patient is intraoperatively misdiagnosed with lung cancer based in the frozen section; hence, wedge resection is a viable option for small peripheral lesions (11).
In conclusion, AA is a rare, benign lung tumor. When encountering a well-defined solitary nodule with cystic spaces in the peripheral lung, an intraoperative diagnosis can be challenging. Therefore, it is critical to consider the possibility of AA, complete the surgery with a wedge resection and await the final pathological diagnosis.
Acknowledgements
Not applicable.
Funding Statement
Funding: No funding was received.
Availability of data and materials
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Authors' contributions
HM was a major contributor to the conception of the study, as well as to the literature search for related studies. TU, NM, YT, TS and HH were involved in the literature review, and in the examination and interpretation of the patient's data. HM, KI, KT and TM were involved in the literature review, in the design of the study, in the critical revision of the manuscript and in the processing of the figures. KI and KT were the pathologists who performed the histopathological diagnosis of the patient. HM and TM confirm the authenticity of all the raw data. All authors have read and approved the final manuscript.
Ethics approval and consent to participate
The patient provided written informed consent for participation.
Patient consent for publication
Written consent was obtained from the patient for the publication of his data and any related images.
Competing interests
The authors declare that they have no competing interests.
References
- 1.Yousem SA, Hochholzer L. Alveolar adenoma. Hum Pathol. 1986;17:1066–1071. doi: 10.1016/s0046-8177(86)80092-2. [DOI] [PubMed] [Google Scholar]
- 2.Klaveren RJ, Oudkerk M, Prokop M, Scholten ET, Nackaerts K, Vernhout R, Iersel CA, Bergh KAM, Westeinde SV, Aalst C, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med. 2009;361:2221–2229. doi: 10.1056/NEJMoa0906085. [DOI] [PubMed] [Google Scholar]
- 3.MacMahon H, Naidich DP, Goo JM, Lee KS, Leung ANC, Mayo JR, Mehta AC, Ohno Y, Powell CA, Prokop M, et al. Guidelines for management of incidental pulmonary nodules detected on CT Images: From the fleischner society 2017. Radiology. 2017;284:228–243. doi: 10.1148/radiol.2017161659. [DOI] [PubMed] [Google Scholar]
- 4.Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. Introduction to the 2015 World Health Organization classification of tumors of the lung, pleura, thymus, and heart. J Thorac Oncol. 2015;10:1240–1242. doi: 10.1097/JTO.0000000000000663. [DOI] [PubMed] [Google Scholar]
- 5.Bhavsar T, Uppal G, Travaline JM, Gaughan C, Huang Y, Khurana JS. An unusual case of a microscopic alveolar adenoma coexisting with lung carcinoma: A case report and review of the literature. J Med Case Rep. 2011;5(187) doi: 10.1186/1752-1947-5-187. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Sak SD, Koseoglu RD, Demirag F, Akbulut H, Gungor A. Alveolar adenoma of the lung. Immunohistochemical and flow cytometric characteristics of two new cases and a review of the literature. APMIS. 2007;115:1443–1449. doi: 10.1111/j.1600-0463.2007.00762.x. [DOI] [PubMed] [Google Scholar]
- 7.Hsieh MS, Tseng YH, Hua SF, Chou YH. Cystic alveolar adenoma: An unusual clinical presentation of a rare lung neoplasm. Pathology. 2015;47:78–80. doi: 10.1097/PAT.0000000000000201. [DOI] [PubMed] [Google Scholar]
- 8.Burke LM, Rush WI, Khoor A, Mackay B, Oliveira P, Whitsett JA, Singh G, Turnicky R, Fleming MV, Koss MN, Travis WD. Alveolar adenoma: A histochemical, immunohistochemical, and ultrastructural analysis of 17 cases. Hum Pathol. 1999;30:158–1567. doi: 10.1016/s0046-8177(99)90270-8. [DOI] [PubMed] [Google Scholar]
- 9.Wang L, Wang X, Rustam A, Hu J. Alveolar adenoma resected by thoracoscopic surgery. Ann Thorac Cardiovasc Surg. 2013;19:489–491. doi: 10.5761/atcs.cr.13-00118. [DOI] [PubMed] [Google Scholar]
- 10.Kondo N, Torii I, Hashimoto M, Takuwa T, Tanaka F, Tsujimura T, Hasegawa S. Alveolar adenoma of the lung: A case report. Ann Thorac Cardiovasc Surg. 2011;17:71–73. doi: 10.5761/atcs.cr.09.01504. [DOI] [PubMed] [Google Scholar]
- 11.Saji H, Okada M, Tsuboi M, Nakajima R, Suzuki K, Aokage K, Aoki T, Okami J, Yoshino I, Ito H, et al. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): A multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet. 2022;399:1607–1617. doi: 10.1016/S0140-6736(21)02333-3. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

